Protocol Ledger

NCT04333537 · Phase II/III · RECRUITING

Comparing Sentinel Lymph Node (SLN) Biopsy With Standard Neck Dissection for Patients With Early-Stage Oral Cavity Cancer

Interventional Phase II/III clinical trial protocol NCT04333537 sponsored by NRG Oncology in Oncology and Hematology, reconciled from NIH NLM ClinicalTrials.gov REST API v2.

Start Date: 2020-09-23 Enrollment: 686 participants (ESTIMATED) Federal Source: clinicaltrials.gov/study/NCT04333537
Track in Studio / Generate Client Brief ->
Registered Enrollment vs Phase II/III Median (145 pts)686 participants (ESTIMATED)
Disclosed U.S. Hospital Campuses vs Median (6 sites)4 sites

Reconciled ClinicalTrials.gov v2 Protocol Specification

Structured Registry Fields for NCT04333537
Protocol FieldVerified Registry Value
NCT IdentifierNCT04333537
Consolidated Lead SponsorNRG Oncology
Therapeutic Condition CohortOncology and Hematology
Clinical Trial PhasePhase II/III
Overall Recruitment StatusRECRUITING
Registered Enrollment686 participants (ESTIMATED)
Registered Start Date2020-09-23
WhyStopped ClassificationNot Stopped

Named U.S. Hospital Clinical Research Sites

Search related sites and sponsors in the Interactive Directory, explore Oncology and Hematology Benchmarks, or read the Healthcare Price & Patent Cliff Crosswalk.

Need custom healthcare data pipelines, identifier crosswalks, or workflow automation? Talk to Meru AI